Establishing an efficient operational strategy from the start in order to launch a successful trial
|
|
- Donna Jennings
- 6 years ago
- Views:
Transcription
1 Establishing an efficient operational strategy from the start in order to launch a successful trial Dr. Gerald Grossheinrich-Pitschke Head Clinical Trial Delivery 5th Clinical Trials Innovation Program (CTIP) June 27-28, Hamburg, Germany
2 Disclaimer The views and opinions expressed in the following presentation are those of the individual presenter and should not be attributed to any organization with which the presenter is employed or affiliated Seite 2
3 From an operational perspective what does succesful mean? Recruitment hits the target What could be the reasons that clinical trials miss the target? The protocol is the basis for a successful clinical trial The Set-up is the second important pillar Typical challenges during Set-up can be linked to: The Do-ability has gaps Feasibility is not well-thought through Planning is too optimistic Do you have the right Outsourcing model? Seite 3
4 Outsourcing models Outsourcing Strategies and Practices to Improve Efficiency and Performance; Aug 11, 2015; By Mary Jo Lamberti, PhD, Frances Grote, Murray A. Abramson, MD, Kenneth A. Getz; Applied Clinical Trials Seite 4
5 Drivers for Outsourcing? What are the drivers for outsourcing? Nice Insight survey during ; Seite 5
6 How to shape collaboration? What can be done to optimize the collaboration between Sponsor and Service Provider (SP)? Sponsors and Service Providers sometimes mention the following as areas which need to be considered: Trust Transparency Communication style Adaption of processes Clear responsibilities Seite 6
7 How to collaborate best? An outsourcing model should enhance the collaboration between Sponsor and Service Provider. This will improve the relationship and increase performance and efficiency. If this works during the Set-up phase then this will work during the conduct of the trial too. Seite 7
8 Simplification To simplify the collaboration with your SP carefully think about the Standard Operating Procedures (SOPs) to be used during the clinical trial. Further avenues need to be examined as well, including: Documents Systems Contracting Handovers Seite 8
9 Communication Service Providers and Sponsors need to be partners during the clinical trial in order to: Discuss on an equal level Increase transparency Exchange of expectations don t forget to document those in - contracts - operational manual - decision logs Seite 9
10 Innovation Less than half of clinical trials conducted today incorporate some type of innovative component. * * Innovations could be: Usage of online pre-screening before site initiation Using data on site-performance from thousands of trials Usage of electronic Informed Consent Form (eicf) *The 2015 Avoca Report - Clinical Development Innovation Seite 10
11 Specialization & Training Clinical Research in general has become much more complex than in the past. Therefore, it becomes consistently more important to retain trained and qualified individuals for as long as possible and create specialized groups like a Trial Set-Up Team Seite 11
12 How to optimize the Set-Up? Leading operational Do-ability for each envisaged country collecting information on: standard of care availability of comparator export/import requirements regulatory requirements patient organizations local treatment guidance Preparation of a well-thought operational feasibility Support selection of potential sites Seite 12
13 How to optimize the Set-Up? Planning and defining the recruitment strategy involvement of professional patient recruitment organization(s) involvement of patient interest/advocacy groups compensatory (back-up) strategies from beginning clarity on wanted and needed countries Raise awareness of all anticipated risks - develop mitigation strategy before things do not go according to plan Creation of project plan with reasonable milestones Plan your budget don t underestimate the costs Seite 13
14 Performance Most Key Performance Indicators (KPIs) defined in the literature assess the performance after First Subject In (FSI). However, most critical is the Set-up phase of a clinical trial. A correction of an suboptimal Set-Up after FSI costs a lot of time and money. A bad performance during the Set-Up phase is hard to detect. KPIs could be: % of sites actively contributing to online pre-screening before site initiation % of submissions according to planned target Number of major protocol revisions EUCROF WEBINAR - 21Apr2016 Performance metrics in the collaboration between Sponsor and CRO, Philippe Van der Hofstadt, CEO of B&C Group Antoinette van Dijk, Chair Working Group Education & Training EUCROF Seite 14
15 Summary GRÜNENTHAL Name der Präsentation Datum Seite 15
16 Summary How to establish an efficient operational strategy from the start in order to launch a successful trial? The following parameters should be considered: Do-ability (protocol) Feasibility (country & sites) Selection of potential sites Define recruitment strategy incl. back-up strategy Creation of project plan Budget plan Seite 16
17 Thanks for listening Dr. Gerald Grossheinrich gerald.grossheinrich-pitschke[at]grunenthal[dot]com GRÜNENTHAL Name der Präsentation Datum Seite 17
White Paper INTRODUCING A COMPLEXITY SCORING SYSTEM IN CONTRACT NEGOTIATION
White Paper INTRODUCING A COMPLEXITY SCORING SYSTEM IN CONTRACT NEGOTIATION Table of Contents 1. Introduction... 3 2. The Key Drivers For Study Startup Performance... 3 3. Contracts Negotiation Parallel
More informationMeeting sponsor s criteria : strategy to collaborate, engage and deliver
Meeting sponsor s criteria : strategy to collaborate, engage and deliver Frédérique Couttet Clinical Trial Manager 4th Annual Outsourcing in Clinical Trials Europe Brussels, Switzerland, May 21 22, 2014
More informationCRO Oversight - Laissez-faire vs. Micromanagement - oder: Wie viel ist zu viel?
CRO Oversight - Laissez-faire vs. Micromanagement - oder: Wie viel ist zu viel? X. Interdisziplinaeres Expertengespraech, PPH plus Frankfurt, Mai 8 th, 2015 Jens Opitz Head Corporate Clinical Operations
More informationThe Safety Case as a basis for more effective outsourcing of writing of aggregate safety reports
The Safety Case as a basis for more effective outsourcing of writing of aggregate safety reports Dr Brian Edwards Scientific Adviser, Pharmacovigilance & Drug Safety, NDA Regulatory Science Ltd DIA 3rd
More informationFRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?
FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up? The following framework of characteristics focuses on attributes that are within the control of investigators and their
More informationWhat Could Go Wrong? ICH E6 R2, Investigative Sites and Risk Assessment Module 2 of a 4 Part Series
What Could Go Wrong? ICH E6 R2, Investigative Sites and Risk Assessment Module 2 of a 4 Part Series Jill Collins Executive Director, Global Operations Management, Syneos Health Mike Walega Executive Director,
More informationEUCROF Presentation. EMA Roundtable meeting with stakeholders on the 10-year anniversary of the SME Office. 27 November 2015 London
EUCROF Presentation EMA Roundtable meeting with stakeholders on the 10-year anniversary of the SME Office 27 November 2015 London Dr. Stefano Marini, MD EUCROF President European Contract Research Organization
More informationWelcome. Thank you for joining us. Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services
Welcome Thank you for joining us Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services 360 o SERVICE PERFORMANCE MEASUREMENT Sponsor View TM 5 Assessments Available
More informationCRO/SPONSOR COOPERATION: COLLABORATING FOR A SUCCESSFUL OUTCOME
CRO/SPONSOR COOPERATION: COLLABORATING FOR A SUCCESSFUL OUTCOME Vibeke Breinholt Director, Clinical Operations, Ferring Pharmaceuticals A/S 18 September 2014 Presentation Overview 1. How to choose the
More informationKPI ENCYCLOPEDIA. A Comprehensive Collection of KPI Definitions for PHARMACEUTICALS
KPI ENCYCLOPEDIA A Comprehensive Collection of KPI Definitions for PHARMACEUTICALS www.opsdog.com info@opsdog.com 844.650.2888 Table of Contents Pharmaceuticals KPI Encyclopedia Pharmaceuticals Metric
More informationHow to rescue a clinical trial
How to rescue a clinical trial Clinical trial conduct is demanding and rigorous, especially in orphan indications where patient populations are small. Even well-qualified, specifically selected Contract
More informationRisk Management in Clinical Trials in Today s ICH-GCP(R2) Framework
Clinical Research in Resource Limited Settings: Mission Impossible or Role Model for Future Drug Development? Risk Management in Clinical Trials in Today s ICH-GCP(R2) Framework Ingrid Klingmann, MD, PhD,
More informationCreating the ideal Approach to gain Balance between effective Oversight and Micromanaging
Creating the ideal Approach to gain Balance between effective Oversight and Micromanaging Karine Pigache-Renard and on behalf of Ulrike M. Grimm 4 th Annual Outsourcing in Clinical Trials Europe Conference,
More informationPAREXEL STRATEGIC PARTNERSHIPS. Optimizing relationships for shorter time to market
PAREXEL STRATEGIC PARTNERSHIPS Optimizing relationships for shorter time to market YOUR JOURNEY. OUR MISSION. Delivering a more collaborative and operationally efficient relationship so you can reach your
More informationEffective Project Leadership and Management: Disclaimer
Effective Project Leadership and Management: A CRO Perspective Nita Ichhpurani, B.S., PMP Director, Drug Development Disclaimer The views and opinions expressed in the following PowerPoint slides are those
More informationLeading Provider of Technology-Enabled Solutions for Clinical Research
Leading Provider of Technology-Enabled Solutions for Clinical Research SUCCESSFUL CLINICAL TRIALS REQUIRE THE ABILITY TO SEE KEY DETAILS AND UNCOVER HIDDEN INSIGHTS. utilizes science and technology to
More informationTackling the Tribulations of Clinical Trials with Research Technology
Tackling the Tribulations of Clinical Trials with Research Technology Kyle Byron Clinical Conductor CTMS Krissy Bouchard Raleigh Neurology October 15, 2016 Faculty Disclosure In compliance with ACCME Guidelines,
More informationInnovative strategies to improve R&D ROI
Innovative strategies to improve R&D ROI Ed Stelmakh, CPA, CMA Vice President and CFO Otsuka America Pharmaceutical, Inc. DISCLAIMER: The following presentation represents the opinions of the speaker and
More informationClinical Trial Performance Metrics
Clinical Trial Performance Metrics Clinical trial performance metrics? Data points that provide insight into operational and quality of performance. Objectives of Clinical Trial Performance Metrics The
More informationIXRS DATA TO INFORMED DECISION MAKING. Linda Chan-Kim October 2015
IXRS DATA TO INFORMED DECISION MAKING Linda Chan-Kim October 2015 Table of Contents Genentech Overview EMMA Data Issues What did we do? 2 2 Roche Group An innovation network 3 South San Francisco is home
More informationHuman Research Protection Program Policy
Page 1 of 5 REVIEW OF INVESTIGATIONAL NEW DRUG (IND)/INVESTIGATIONAL DEVICE EXEMPTION (IDE) RESEARCH IN HUMAN SUBJECTS RESEARCH POLICY It is the policy of the University of Cincinnati that studies involving
More informationRecommendations for Strengthening the Investigator Site Community
Recommendations for Strengthening the Investigator Site Community October 2017 CTTI MISSION: To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials
More informationInvestigational Medicinal Product (IMP) Management Standard Operating Procedure
Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support
More informationOctober 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationRisk-Based Monitoring - Prospective from CRO
Risk-Based Monitoring - Prospective from CRO New Trends in Clinical Trials Taipei 2016 Tong Guo, PhD Head of Biostatistics, Africa & Asia QuintilesIMS Copyright 2015 Quintiles Disclaimer The views and
More informationData-Driven Strategies for Improved Site Activation and Patient Enrollment Forecasting
Data-Driven Strategies for Improved Site Activation and Patient Enrollment Forecasting Introduction PRESENTERS Mark Shapiro, MA, MBA Vice President, Clinical Development Clinipace Worldwide Cindy Venendaal,
More informationMini Summit IV: Advanced Issues in Transparency and Disclosure - Research and Clinical Trials Update
Mini Summit IV: Advanced Issues in Transparency and Disclosure - Research and Clinical Trials Update Dr. Jessica Santos Global Compliance and Quality Director 17 August 2015 Meaning of Pharma/Life Science
More informationVeeva 2017 Unified Clinical Operations Survey
PRELIMINARY FINDINGS Veeva 2017 Unified Clinical Operations Survey The Veeva 2017 Unified Clinical Operations Survey examines the life sciences industry s progress toward a unified clinical environment
More informationPERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL FEEDBACK PROCESS HRA APPROVED TRIALS
PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL FEEDBACK PROCESS HRA APPROVED TRIALS Version Control New document 1 Acronyms CTP DSC DSS FPR HRA MHRA REC SOP Clinical Trial Performance
More informationVendor-Sponsor Successful Communication. Nathalie Dutil Nov 2012
Vendor-Sponsor Successful Communication Nathalie Dutil Nov 2012 It s all about setting expectations. Lack of communication Miscommunication Presentation overview Strategic Sourcing Oversight Model Trust
More informationENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL
Shaping the Future of Drug Development ENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL Jim Baker Senior Vice President Clinical Research Services Cytel JIM BAKER Senior
More informationSingapore Clinical Research Professional (CRP) /Clinical Research Coordinator Society (CRCS) Forum
Singapore Clinical Research Professional (CRP) /Clinical Research Coordinator Society (CRCS) Forum 25 August 2017 TOPIC: Issue Management / Quality Risk Management Implications with ICH GCP E6 (R2) and
More informationVeeva 2018 Unified Clinical Operations Survey
PRELIMINARY FINDINGS Veeva 2018 Unified Clinical Operations Survey The Veeva 2018 Unified Clinical Operations Survey examines the life sciences industry s progress toward a unified clinical environment
More informationBIOCLINICA SITE & PATIENT PAYMENTS
BIOCLINICA SITE & PATIENT PAYMENTS Improve cash management and financial risk mitigation as well as site payment transparency, control and accuracy, while reducing payment-related workload and costs, with
More informationTransCelerate Overview. Tozheg Roshankar
TransCelerate Overview Tozheg Roshankar 11, Aug, 2016 TransCelerate is a not for profit entity created to drive collaboration Our vision To improve the health of people around the world by accelerating
More informationSummary of Day 1. Christopher Granger
Summary of Day 1 Christopher Granger 508 million tweets Across the globe 2008 to 2010 Science Sept 30 2011 Selected Points Large simple trials are not so simple, and can also be called large streamlined
More informationEU Clinical Trial Regulation A view from the Industry
Conference EU Clinical Trial Regulation EU Clinical Trial Regulation A view from the Industry Judith Creba, Executive Director, EU Regulatory Strategy, Novartis Pharma AG University of Basel, Law Faculty
More informationBEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM
BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM Six steps to ensuring risk-based quality management in clinical trials EVOLVING REGULATIONS ON RISK-BASED MONITORING In 2016, the International
More informationRealising Leadership (RLP) Achieving manufacturing excellence through leadership
Realising Leadership Potential (RLP) Achieving manufacturing excellence through leadership Realising Leadership Potential How do we evolve leaders as well as up-skilling managers? The best manufacturing
More informationMulti-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes
WHITE PAPER Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes Author: SCOTT SCHLIEBNER Vice President, Rare Disease - Scientific Affairs
More informationComplex Care Program Development: A New Framework for Design and Evaluation
BRIEF MARCH 2017 Complex Care Program Development: A New Framework for Design and Evaluation By David Labby, MD, PhD * IN BRIEF While medical-technological interventions undergo robust research and design
More informationProject Delivery Excellence
Project Delivery Excellence Raising the bar in project success 1 ICONplc.com Contents Raising the bar in project success 03 Tailored training and development 04 Project planning and management for predictable
More informationSponsor/CRO Partnership Optimization
Insight Brief Sponsor/CRO Partnership Optimization Developing a CRO Governance Model Geoff Garabedian, Vice President and Managing Director, Consulting at Quintiles Josh Samon, Principal Life Sciences
More informationExploring the Importance of Instilling a Sense of Ownership in the Vendor and Making Them Feel Involved and Motivated Through the Trial Cycle
Exploring the Importance of Instilling a Sense of Ownership in the Vendor and Making Them Feel Involved and Motivated Through the Trial Cycle Natasha Sabljic November 14, 2012 Outsourcing in Clinical Trials
More informationCorporate Presentation. October 2017
Corporate Presentation October 2017 Company Overview OPIS is an international CRO providing: - A wide range of clinical and e-clinical services for Pharmaceutical and Biotechnology Industries, Medical
More informationELEMENTS OF A DATA MONITORING PLAN
ELEMENTS OF A DATA MONITORING PLAN Definitions Data Monitoring: The regular evaluation of data and documentation collected during a study to ensure both adherence to the approved investigative plan and
More informationClinical Trial Outsourcing: A Case Study For Small Biotechnology Companies Operating Globally
Clinical Trial Outsourcing: A Case Study For Small Biotechnology Companies Operating Globally Cerus Corporation Concord, CA Laurence Corash, MD Chief Medical Officer Meisa Propst, Associate Director Clinical
More informationIncorporating Risk- Based Monitoring Strategies: Challenges in Implementation Sherri Hubby, Director, U.S. Quality Assurance
Incorporating Risk- Based Monitoring Strategies: Challenges in Implementation Sherri Hubby, Director, U.S. Quality Assurance 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria. Disclaimer The
More informationSTUDY DOCUMENTS. DOCUMENT NO.: CR007 v4.0. Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 EFFECTIVE DATE: 21 MAR INTRODUCTION
STUDY DOCUMENTS DOCUMENT NO.: CR007 v4.0 AUTHOR: Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint office
More informationSelecting A Right Patient Recruitment Company: The Key To Success
Selecting A Right Patient Recruitment Company: The Key To Success A R T I C L E Toll Free Number: 1-888-987-2691 www.makrocare.com/mcsmo 1 With current global economic uncertainty, intense global competition,
More informationThe Science of Small Clinical Trials
The Science of Small Clinical Trials Introduction to Small Clinical Trials an Industry Perspective Simon Day, PhD Confucius (allegedly) When it is obvious that the goals cannot be reached, don t adjust
More informationInvestigator Satisfaction Survey Marketing department
Investigator Satisfaction Survey 2005 Marketing department 1 Who answered the questionnaire? How do investigators usually contact Clirophtha? Our clinical research activity E-CRFs What do investigators
More informationConstructing an etmf 12/2/2011. consider your current etmf structure!! The do s and don ts of EDM. Disclaimer
Constructing an etmf The do s and don ts of EDM Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug
More informationTalking to Active Investigators: Interview Findings
April 5, 2017 Talking to Active Investigators: Interview Findings Terri Hinkley RN, BScN, MBA, CCRC Association for Clinical Research Professionals (ACRP) Active Investigator Interviews Active Investigator:
More informationEuropean Stroke Journal: Declaration Guidelines for Authors
Table of Contents 1. Human Research and In Vitro Studies... 2 Required Declarations... 2 Example of a completed declarations section... 2 Example of text that should be used if any declaration is not relevant
More informationCompliance Program Guidance Manuals (CPGMs) -1-
Inspector s Preparation for a CI Inspection: FDA Compliance Program & the Records Inventory Jean Toth-Allen, Ph.D. APEC GCP Inspection Workshop May 28, 2008 Compliance Program Guidance Manuals (CPGMs)
More informationThe Importance of Feasibility Studies for Oncology Clinical Trials
The Importance of Feasibility Studies for Oncology Clinical Trials www.ppdi.com Executive Summary The segmenting of the oncology patient population has increased the challenges in designing clinical trials.
More informationDocument Title: Annual Progress Reports (APRs) Document Number: 056
Document Title: Annual Progress Reports (APRs) Document Number: 056 Version: 1 Ratified by: Committee Date ratified: 30/11/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationTHE NEW PARADIGMS IN ONCOLOGY CLINICAL TRIALS. Quality Risk Assessment (RBM) & electronic Informed Consent (eic)
THE NEW PARADIGMS IN ONCOLOGY CLINICAL TRIALS Quality Risk Assessment (RBM) & electronic Informed Consent (eic) DEFINITION OF RISK The combination of the probability of occurrence of harm and the severity
More informationOutsourcing in Clinical Trials Europe 2014
TIME TO BUST E-RECRUITMENT MYTHS! Outsourcing in Clinical Trials Europe 2014 21-22 May 2014, Brussels, Belgium you not only saved us a couple of months time, but definitively disproved two myths that have
More informationJPMSA JOURNAL OF THE PHARMACEUTICAL MANAGEMENT SCIENCE ASSOCIATION SPRING 2014
JPMSA JOURNAL OF THE PHARMACEUTICAL MANAGEMENT SCIENCE ASSOCIATION SPRING 2014 1 ARTICLE 2 Unlocking the Value of Closed Loop Marketing Analytics to Drive Customer Centricity Pratap Khedkar, Managing Principal,
More information22 nd February Utilizing big data to enhance patient recruitment
22 nd February 2017 Utilizing big data to enhance patient recruitment Overview Barriers to recruitment success Current solutions to overcome recruitment barriers Outsourcing (3 rd Party Vendors, CROs)
More informationthe council initiative on public engagement
public engagement at the city of edmonton share your voice shape our city the council initiative on public engagement new public engagement practice and implementation roadmap final report CITY OF EDMONTON
More informationNPSO Ltd. Participant Community Event 17 th January Aldersgate, London. For internal use only
Participant Community Event 17 th January 2018 200 Aldersgate, London Agenda 1. NPSO Purpose and Approach 2. NPSO Transition - Programme Status 3. Stakeholder Opportunities & Communications 4. Independent
More information5 th Training Workshop for Micro-, Small- and Medium- Sized Enterprises (SMEs)
5 th Training Workshop for Micro-, Small- and Medium- Sized Enterprises (SMEs) GCP Requirements and Compliance Dr. Katalina Mettke BfArM, Germany Agenda Specialities of Early Development Trials Examples
More informationVeeva 2015 Paperless TMF Survey: Annual Report
Veeva 2015 Paperless TMF Survey: Annual Report REMOVING PAPER FROM THE PROCESS The Veeva 2015 Paperless TMF Survey explores the life sciences industry s progress toward paperless clinical trials by gathering
More informationSponsors, CROs and all
Sponsors, CROs and all the Rest Disclaimer The views and opinions expressed in the following PowerPoint presentation represent the opinions of the author / speaker and should not be construed as the position
More informationAlmac ONE: One Unified Clinical Trial Supply Solution
Almac ONE: One Unified Clinical Trial Supply Solution There is ONE solution to solving the challenges of managing multiple supply chain vendors... Almac ONE - Your ONE Unified Solution Solution has redefined
More informationThe future and value of innovation in the NHS
The future and value of innovation in the NHS Royal Academy of Engineering Conference 15 November 2011 Mirella Marlow Programme Director Agenda A few words about NICE A few words about innovation What
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationmedicines, improving the health of people around the world.
TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to identify, design and facilitate the implementation
More informationWE CARE MEDTECH.
MEDTECH WE CARE Clinical Research & Development Consulting & Strategy Clinical trials Post-Marketing Observational Studies Market Access www.vivactis.com May 2016 WHAT WE DO Clinical Research & Development
More informationClinical Trials Series Part II
Clinical Trials Series Part II Agenda Recap December Presentation J. Schmelz Example: New CT from HSC Investigator Non Cancer Clinical Trial J. Bates, P. Miranda Example: New CT from External Entity Non
More informationINTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING
INTRODUCING CLINIC AUTOMATION IN A PHASE I UNIT WITH END-TO-END E-SOURCE DATA PROCESSING Wim Verreth 4 th Annual Outsourcing in Clinical Trials 21-22 May 2014 OUTLINE What is Clinical Automation? Why we
More informationDEVELOPING A PERSUASIVE BUSINESS CASE FOR CRM. Glenda Parker
DEVELOPING A PERSUASIVE BUSINESS CASE FOR CRM Glenda Parker CONTENTS INTRODUCTION 2 1. HAVE AN EXECUTIVE SUMMARY (BUT WRITE IT LAST) 3 2. CLEARLY OUTLINE THE PROJECT PURPOSE 3 3. IDENTIFY ALL KEY STAKEHOLDERS
More informationVendor Selection: Identifying Effective Procedures & Strategies
Outsourcing Clinical Trials Canada 15 th November 2012 Vendor Selection: Identifying Effective Procedures & Strategies John S Andrews PhD President and CSO, NeurAxon Inc President, Ketogen Inc CSO, Talon
More informationEthics Committees/IRBs Today: Challenges for Efficiency and Quality
Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients
More informationFood and Drug Administration Guidance: Supervisory Responsibilities of Investigators
Journal of Diabetes Science and Technology Volume 5, Issue 2, March 2011 Diabetes Technology Society REVIEW ARTICLE Food and Drug Administration Guidance: Supervisory Responsibilities of Investigators
More informationFDA Perspective on International Clinical Trials
FDA Perspective on International Clinical Trials Kassa Ayalew, M.D., M.P.H. Division of Clinical Compliance Evaluation (DCCE) Office of Scientific Investigations (OSI) Center for Drug Evaluation and Research
More informationCRO Outlook 2015: A Paperless Path to a Competitive Advantage
CRO Outlook 2015: A Paperless Path to a Competitive Advantage Dec 22, 2014 By Jennifer Goldsmith Applied Clinical Trials All signs indicate that 2015 should be another good year for contract research organizations
More informationHighlights of the proposed Clinical Trials Regulation in Europe
Highlights of the proposed Clinical Trials Regulation in Europe Dr Daryl Rees 22 January 2013 Proposed Clinical Trials Regulation On 17July 2012, the Commission adopted the proposal for a "Clinical Trials
More informationClinical trial applications in the EU and US
Clinical trial applications in the EU and US Alain Patat, M.D. Translational Development Wyeth Research Paris, France AGAH-Club Phase 1 1 st Symposium Strasbourg 17-18 March 2005 Overview of the presentation
More informationTimeliness of TMF Document Submission: from Finalized to Filed
Timeliness of TMF Document Submission: from Finalized to Filed Vittoria Sparacio, MSc CBI s etmf Forum Hyatt at de Bellevue Philadelphia 18 November 2014 Finally my turn to say... I know I am standing
More informationTechnology to Transform Your Clinical Trials
Technology to Transform Your Clinical Trials DrugDev Spark is the only unified clinical solutions suite with proven success for hundreds of sponsors and CROs Spark Spark TM DrugDev Spark is the answer
More informationConfirming Research Study Capacity and Capability
Title: Outcome Statement: Written By: Confirming Research Study Capacity and Capability Researchers will be informed about the procedures and requirements for obtaining permission to conduct a research
More informationVolunteer Coordinator
Volunteer Coordinator Ronald McDonald House Charities believes that it s people are an essential part of the Charity and value them and their contribution. This Success Profile adds to the overall value
More informationChallenges of Analytical Method Transfer in the Pharmaceutical Industry
Challenges of Analytical Method Transfer in the Pharmaceutical Industry White Paper Author: Steve Alley, Technical Specialist 1 Contents Introduction 2 Method Transfer Team 3 Identify Methods 4 Gap Analysis
More informationTransparency as a Good Business Practice
Transparency as a Good Business Practice Exploring How Transparency Can Drive Best Practices in Business Strategy August 2017 Polaris Management Partners Agenda Compliance Trends 2017-2018 Deriving Strategic
More informationJournal of Clinical Urology (JCU): Declaration Guidelines for Authors
Table of Contents 1. Case Report or Case Series... 2 Required Declarations... 2 Example of a completed declarations section:... 2 Example of text that should be used if any declaration is not relevant
More informationStreamlining IRB Procedures for Expanded Access
Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs
More informationPanel Discussion MINI SUMMIT XIII: global fair market value update
Panel Discussion MINI SUMMIT XIII: global fair market value update Introduction Panel Swee Kheng Khor, MD, Associate Director, Office of Ethics and Compliance, Middle Eastand Pakistan, AbbVie BioPharmaceutical
More informationAnatomy of an FDA Audit Trigger Prevention and Process
Robert S. Walsh, MD, MBA, FAHA, FCCP Walsh Medical Consulting 15 th Annual Product Complaints Congress Crystal City, VA 14 June 2017 How many here are from Pharma? Medical Device Industry? Biotechnology?
More informationAspects of IBCs in Multicent Multicen er t Clinical Trials Daniel Kavan Kava agh, PhD
Aspects of IBCs in Multicenter Clinical Trials Daniel Kavanagh, PhD Disclosure DGK is employed by WIRB Copernicus Group, a provider of externally administered IBC Services. About Me Senior Director, Biosafety
More informationPhlexEview: Transforming Costly Paper Processes into Value Driven Compliance
PHLEXGLOBAL WHITE PAPER PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance Presented By: Karen Redding Global Business Development Director Phlexglobal, Ltd. kredding@phlexglobal.com
More informationKey Opinion Leader Development. Tony Moses President, A-Z Eye Consultants National Manager, eyecheck LLC
Tony Moses President, A-Z Eye Consultants National Manager, eyecheck LLC What defines a KOL? What are the most important KOL activities? Why build a KOL Program? How to build a KOL Program? When to begin
More informationLearning about Clinical Trials
Learning about Clinical Trials A Guide for Individuals and Their Loved Ones INTRODUCTION Clinical trials help researchers answer important medical questions, providing information that may help with the
More informationQUALITY quality standard that the data are credible and the rights, safety, integrity and confidentiality of the subjects are protected HOW???
L.Massad GCP an International Ethical and Scientific quality standard by which clinical trials are designed, implemented and reported so that there is public assurance that the data are credible and the
More informationChallenges of Multicenter Studies in Europe, EURECNET, Bratislava, 13 April 2012
Challenges of Multicenter Studies in Europe, EURECNET, Bratislava, 13 April 2012 Hartmut Krafft, PhD CTFG-Chair VHP-Coordinator Head, Section clinical trials Paul-Ehrlich-Institut Paul-Ehrlich-Str. 51-59
More informationStandard Operating Procedure
Standard Operating Procedure 6.0.1 New Study Ideas/Proposals History Version Date Author Reason 1.0 27 th August 2013 Linda Devilee To document the process and support provided by PaCCSC for new study
More informationMedical Research: Participation Issues
Medical Research: Participation Issues Key Points Types of medical solutions vary Various factors influence support & adoption Clinical trials are a critical, expensive piece of the approval process Threat
More information